TAG-72 Antibody (rTAG72/9132) [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-23987B
Recombinant Monoclonal Antibody

Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry-Paraffin
Label
Biotin
Antibody Source
Recombinant Monoclonal Mouse IgG1 kappa Clone # rTAG72/9132
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Membrane-enriched fraction of a human breast carcinoma liver metastasis
Localization
Cytoplasm. Cell surface.
Specificity
Recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This monoclonal antibody defines the mucin-carried sialylated-Tn epitope. TAG-72 is usually expressed by adenocarcinomas, but is negative in me
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for TAG-72 Antibody (rTAG72/9132) [Biotin]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: TAG-72
Alternate Names
CA 72-4, Protein TAG-72, tag 72, tag-72 Protein TAG-72
Additional TAG-72 Products
Product Documents for TAG-72 Antibody (rTAG72/9132) [Biotin]
Product Specific Notices for TAG-72 Antibody (rTAG72/9132) [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...